Glori Energy Raises $20 Million -- more

Astex Announces Early Transfer of Epigenetics Project to GSK -- more

Shell Strikes Coalbed Natural Gas Recovery R&D Deal with Luca Tech -- more

Xencor Receives U.S. Patent for Monoclonal Antibody Engineering that Extends Duration of Action -- more

Glori Energy Signs Contract with Brazil’s Petrobras -- more

Dicerna Pharmaceuticals Appoints Life Sciences Executive James B. Weissman to Chief Business Officer -- more

Radius Announces Topline Results of Successful Phase 1b Clinical Trial of BA058 Microneedle Patch for the Transdermal Treatment of Osteoporosis -- more

VaxInnate Licenses Recombinant Flu Vaccines To CJ CheilJedang Corporation of South Korea -- more

Radius Closes $21.4 Million Third and Final Equity Tranche of Previously Announced Financing -- more

Dicerna Pharmaceuticals Announces First DsiRNA Therapeutic Candidate Selected for Development, Triggering $5 Million Milestone Payment -- more

ExonHit: AclarusDx® : launch of observational study in France -- more

Radius Transitions Company Leadership; Names Michael Wyzga President and Chief Executive Officer to Advance Phase 3 Osteoporosis Drug and Drive Corporate Strategy -- more

Radius Closes $27.65 Million Second Tranche of Previously Announced Financing -- more

Journal of Petroleum Technology - From Bacteria to Barrels: Microbiology -- more

IntraPace: The 'gastric pacemaker' that warns the brain you're full! Could this device retrain the obese to eat more healthily? -- more

ExonHit Extends Strategic Collaboration with Allergan -- more

Claros Diagnostics - Inc Magazine: Innovation: A Blood Test on a Chip -- more

Dicerna Pharmaceuticals Awarded Notice of Allowance by U.S. Patent and Trademark Office for Patent Claims Broadly Covering Dicer Substrate siRNA Molecules -- more